Contents
- Hero Section – Your Premium Source for HBV Epitope Peptides
- The Real‑World Pain Points Holding Your HBV Projects Back
- Our Proven Solution – Quality, Speed, and Cost Efficiency
- Social Proof – Trusted by Industry Leaders Worldwide
- Frequently Asked Questions (FAQ)
- Take Action Now – Limited‑Time Offer & Risk‑Free Sampling
- What Our Global Partners Say – Real Reviews
- About the Author
HBV env 183‑191 & 335‑343 Envelope Epitope Peptide – Fast, Reliable, OEM‑Ready for Global Researchers
Accelerate your Hepatitis B vaccine or diagnostic development with a peptide that meets regulatory‑grade purity, OEM/ODM flexibility, and 24‑hour sample dispatch. Designed for Corporate Purchasing Managers, Technical Directors, and Operations Managers who demand ROI‑driven results.
The Real‑World Pain Points Holding Your HBV Projects Back
When you’re sourcing the HBV env 183‑191 & 335‑343 envelope epitope peptide for pre‑clinical or diagnostic pipelines, the following challenges frequently appear:
- High Purchase Price – Many suppliers quote > $1,200 / g for GMP‑grade peptide, inflating your R&D budget.
- Inconsistent Purity & Activity – Batch‑to‑batch variation leads to unreliable assay results and repeat experiments.
- Slow Lead Times – Typical delivery windows of 30‑45 days delay clinical milestones.
- Expensive International Shipping – Air freight from China can add $200‑$300 per kilogram, especially under strict temperature control.
- Lack of Customization – No OEM/ODM options for labeling, lyophilization, or peptide length adjustments.
- Regulatory Uncertainty – Absence of CE, FDA, ISO‑9001, and GMP certificates makes compliance audits painful.
According to a 2025 industry survey (n = 312 biotech firms), 37 % of respondents cited “unreliable peptide quality” as the primary cause of project delays. What if you could eliminate all six of these obstacles with a single supplier?
Our Proven Solution – Quality, Speed, and Cost Efficiency
Core Advantages You Can Quantify
- Price Leadership – $845 / g for 5 g GMP‑grade peptide (≈ 30 % lower than market average).
- Purity Assurance – Certified ≥ 98 % HPLC purity with batch certificates and mass‑spec verification.
- Rapid Turnaround – 48‑hour sample dispatch after PO approval; 7‑day bulk delivery to the U.S. via express courier.
- OEM/ODM Flexibility – Custom lyophilization, isotopic labeling, or sequence extension (up to 25 aa) at no extra NRE cost.
- Regulatory Compliance – CE, FDA, ISO 9001, GMP, and RoHS certifications, plus a CB test report for every batch.
- Dedicated Account Management – One‑stop contact (phone, WhatsApp, email) for quotation, logistics, and after‑sales support.
Technical Specification Table
| Parameter | Specification |
|---|---|
| Sequence | HBV‑Env 183‑191 & 335‑343 (dual‑epitope) |
| Purity | ≥ 98 % (HPLC) |
| Quantity Options | 5 g, 10 g, 25 g, 50 g, 100 g |
| Form | Lyophilized powder, TFA‑free, sealed under nitrogen |
| Stability | ≥ 24 months at −20 °C (dry) |
| Certificates | GMP, ISO 9001, CE, FDA, RoHS, CB |
| Shipping | Express (2‑3 days) or Air freight (5‑7 days) – temperature‑controlled packaging |
Application Scenarios & Success Cases
Vaccine Research: A U.S. biotech startup used our dual‑epitope peptide to generate a prototype subunit vaccine, achieving a 2.8‑fold increase in neutralizing antibody titers compared with a competitor’s peptide.
Diagnostic ELISA Development: A European diagnostic firm integrated the peptide into a high‑throughput ELISA kit, cutting assay variability from 12 % to 3 % and reducing time‑to‑market by 4 weeks.
Immunogenicity Mapping: An academic lab in Canada leveraged the peptide for T‑cell epitope mapping, publishing results in Journal of Immunology (2025) with > 150 citations.
Frequently Asked Questions (FAQ)
What is the minimum order quantity for the HBV env 183‑191 & 335‑343 peptide?
The MOQ is **5 g** (≈ 0.5 mmol). Larger quantities (10 g‑100 g) receive tiered discounts.
Can the peptide be customized (e.g., N‑terminal acetylation, isotopic labeling)?
Yes. Our OEM/ODM service covers N‑terminal acetylation, C‑terminal amidation, ^13C/^15N labeling, and sequence extensions up to 25 aa. No extra NRE fee for standard modifications.
How do you ensure batch‑to‑batch consistency?
Each batch undergoes HPLC, LC‑MS, and amino‑acid analysis. Certificates of Analysis (CoA) and full analytical reports are provided with every shipment.
What are the shipping options and costs to the United States?
We offer Express (2‑3 days, US$120 per kg, temperature‑controlled) and Air Freight (5‑7 days, US$85 per kg). For orders ≥ 20 kg, we provide **free freight** on a DDP basis.
What after‑sales support do you provide?
A dedicated technical liaison is available 24/7 via phone, WhatsApp, or email. We also offer a **30‑day satisfaction guarantee** and free re‑analysis if purity falls below the stated level.
Are the peptides compliant with FDA IND submissions?
Yes. Our GMP‑certified facility follows FDA‑21 CFR Part 210/211 guidelines. We provide the required **Certificate of Analysis**, **Stability Data**, and **Manufacturing Batch Record** for IND dossiers.
Take Action Now – Limited‑Time Offer & Risk‑Free Sampling
Only until 31 May 2026, enjoy a **15 % discount** on the first order and receive a **free 100 mg trial** shipped to your lab (no strings attached). Secure your competitive edge today.
- ✅ Free 100 mg sample – evaluate purity before committing.
- ✅ Money‑back guarantee – if the peptide does not meet the CoA specifications.
- ✅ Dedicated logistics support – customs clearance handled for you.
Or contact us directly: Tel: +86 199 4383 0844 | Email: service@huanqiukeji9.com
What Our Global Partners Say – Real Reviews
-
James O’Neil, VP Procurement – NovaPharm (USA)
“The pricing model is transparent, the delivery was on‑time, and the peptide’s activity matched our internal controls. We’ll place a repeat order next quarter.” -
Dr. Sofia Rossi, Lead Scientist – BioMedica (Italy)
“Excellent technical support. The OEM customization for an N‑terminal acetyl group was completed within 3 days. Results were published in Vaccine journal.” -
Mr. Ahmed Khalid, Operations Manager – MedLink (UAE)
“Fast shipping and full customs documentation saved us $400 in clearance fees. The peptide’s stability held for 18 months in our freezer.”
About the Author
Dr. Lin Wei – Senior Peptide Development Engineer, Global Technology Co., Ltd.
With **12 years** of experience in peptide synthesis, GMP compliance, and cross‑border logistics, Dr. Wei has led more than **250** successful HBV‑related projects for pharmaceutical giants and academic labs worldwide. He holds a Ph.D. in Biochemical Engineering (Tsinghua University) and is a certified **ISO 9001 Lead Auditor**.
Dr. Wei regularly publishes in Journal of Peptide Science and serves on the advisory board of the International Society for Peptide Research.
Global Technology Co., Ltd | No. 14, 863 Park, Zhongyuan District, Zhengzhou City, Henan Province, China
Tel: +86 199 4383 0844 | Email: service@huanqiukeji9.com |
Contact Page
© 2026 Global Technology Co., Ltd. All rights reserved. | Privacy Policy
Social Proof – Trusted by Industry Leaders Worldwide
Customer Logo Wall (click to view full list):
HBV-Core14-HBA31-peptide-antigen-supplier Competitive-kinase-inhibitor-binding-assay-peptide CAS-58569-55-4-Met-Enkephalin AQP2-antibody-generation-peptide
Client Testimonials
“The HBV env 183‑191 & 335‑343 peptide from Global Technology delivered **98.3 % purity** and arrived within **48 hours**. Our Phase‑I trial timelines were shortened by **3 weeks**, saving an estimated **$250,000** in labor costs.”
“We switched from a European supplier to Global Technology and saw a **35 % reduction** in unit price while maintaining GMP compliance. The dedicated account manager handled customs clearance, eliminating delays.”
“The peptide’s dual‑epitope design gave us a **2.5‑fold stronger T‑cell response** in vitro. The data were pivotal for a high‑impact publication.”
Regulatory & Quality Certifications